References
1a
Bolm C.
Muniz K.
Chem. Soc. Rev.
1999,
28:
51
1b
Deng W.-P.
You S.-L.
Hou X.-L.
Dai L.-X.
Yu
Y.-H.
Xia W.
Sun J.
J. Am Chem. Soc.
2001,
123:
6508
For reviews, see:
2a
Ferrocenes
Togni A.
Hayashi T.
VCH;
Weinheim:
1995.
2b
Richards CJ.
Locke AJ.
Tetrahedron: Asymmetry
1998,
9:
2377
2c
Togni A.
Bieler N.
Burckhardt U.
Köllner C.
Pioda G.
Schneider R.
Schnyder A.
Pure Appl. Chem.
1999,
71:
1531
2d
Dai L.-X.
Hou X.-L.
Deng W.-P.
You S.-L.
Zhou Y.-G.
Pure Appl. Chem.
1999,
71:
1401
3a
Tye H.
Comina PJ.
J. Chem. Soc., Perkin Trans. 1
2001,
1729
3b
Farrell A.
Goddard R.
Guiry PJ.
J. Org. Chem.
2002,
67:
4209
3c
You S.-L.
Hou X.-L.
Dai
L.-X.
Yu Y.-H.
Xia W.
J. Org. Chem.
2002,
67:
4684
4
Gibson SE.
Ibrahim H.
Chem. Commun.
2002,
21:
2465
5a
Gibson SE.
Knight JD.
Org. Biomol. Chem.
2003,
1:
1256
5b
Rozenberg V.
Kharitonov V.
Antonov D.
Sergeeva E.
Aleshkin A.
Ikonnikov N.
Orlova S.
Belokon Y.
Angew. Chem., Int. Ed. Engl.
1994,
33:
91
5c
Pye PJ.
Rossen K.
Reamer RA.
Tsou NN.
Volante RP.
Reider PJ.
J. Am. Chem. Soc.
1997,
119:
6207
5d
Dahmen S.
Bräse S.
J. Am. Chem. Soc.
2002,
124:
5940
5e
Wu X.-W.
Yuan K.
Sun W.
Zhang M.-J.
Hou X.-L.
Tetrahedron: Asymmetry
2003,
14:
107
6a
Lüttringhaus A.
Gralheer H.
Justus Liebigs Ann. Chem.
1942,
550:
67
6b
Lüttringhaus A.
Gralheer H.
Justus Liebigs Ann. Chem.
1947,
557:
108
6c
Lüttringhaus A.
Gralheer H.
Justus Liebigs Ann. Chem.
1947,
557:
112
For reviews, see:
7a
Vögtle F.
Neumann P.
Top. Curr. Chem.
1974,
48:
67
7b
Vögtle F.
Hohner G.
Top. Curr. Chem.
1978,
74:
1
7c
Boekelheide V.
Acc. Chem. Res.
1980,
13:
65
7d
Collet A.
Dutasta J.-P.
Lozach B.
Canceill J.
Top. Curr. Chem.
1993,
165:
103
8a
Vögtle F.
Meurer K.
Mannschreck A.
Stühler G.
Puff H.
Roloff A.
Sievers R.
Chem. Ber.
1983,
116:
2630
8b
Kang GJ.
Chan TH.
J. Org. Chem.
1985,
50:
452
8c
Meurer K.
Luppertz F.
Vögtle F.
Chem. Ber.
1985,
118:
4433
8d
Grimme S.
Pischel I.
Vögtle F.
Nieger M.
J. Am. Chem. Soc.
1995,
117:
157
8e
Hochmuth DH.
König WA.
Liebigs Ann.
1996,
947
8f
Müller D.
Böhme M.
Nieger M.
Rissanen K.
Vögtle F.
J. Chem. Soc., Perkin Trans. 1
1996,
2937
8g
Grimme S.
Harren J.
Sobański A.
Vögtle F.
Eur. J. Org. Chem.
1998,
1491
8h
Iwamoto H.
Yang Y.
Usui S.
Fukazawa Y.
Tetrahedron Lett.
2001,
42:
49
8i
Es DS.
Gret N.
Rijke M.
Eis MJ.
Kanter FJJ.
Wolf WH.
Bickelhaupt F.
Menzer S.
Spek AL.
Tetrahedron
2001,
57:
3557
9a
Schmidtchen FP.
Berger M.
Chem. Rev.
1997,
97:
1609
9b
Kubik S.
Goddard R.
J. Org. Chem.
1999,
64:
9475
9c
Piątek P.
Jurczak J.
Chem. Commun.
2002,
2450
9d
Bondy CR.
Loeb SJ.
Coord. Chem. Rev.
2003,
240:
77
9e
Choi K.
Hamilton AD.
Coord. Chem. Rev.
2003,
240:
101
10a
Gryko DT.
Gryko D.
Jurczak J.
Synlett
1999,
1310
10b
Piątek P.
Gruza MM.
Jurczak J.
Tetrahedron: Asymmetry
2001,
12:
1763
11
General Procedure for Synthesis of Macrocyclic Compounds 10-12: To a mixture of appropriate ester (5 mmol) and appropriate amine (5 mmol) in anhyd MeOH (60 mL) was added solution of MeONa (12.5 mmol) in anhyd MeOH (50 mL). The mixture was left at r.t. for several hours (monitored by TLC). The solvent was evaporated and the residue was purified by column chromatography.
12
Yu MJ.
McCowan JR.
Phebus LA.
Towner RD.
Ho PPK.
Keith PT.
Luttman CA.
Saunders RD.
Ruterbories KJ.
Lindstrom TD.
Wikel JH.
Morgan E.
Hahn RA.
J. Med. Chem.
1993,
36:
1262
13
19-Benzyloxy-2,8,14-trioxa-5,11-diaza-bicyclo[13.3.1]nonadeca-1 (18),15 (19),16-triene-4,12-dione (
10). Purified by column chromatography (silica gel, EtOAc) to give 10 (60%) as a white solid; mp 183.9-184.5 °C. 1H NMR (500 MHz, DMSO-d
6): δ = 7.82-7.76 (m, 2 H, NHCO), 7.60 (d, J = 7.0 Hz, 2 H), 7.48 (t, J = 7.0 Hz, 2 H), 7.43-7.39 (m, 1 H), 7.16 (dd, J
1 = 1.9 Hz, J
2 = 7.3 Hz, 1 H), 7.09 (d, J = 7.8 Hz, 2 H), 5.04 (s, 2 H, CH2Ph), 4.76 (dAB,
J = 16.5 Hz, 2 H, CH2CO), 4.69 (dAB, J = 16.5 Hz, 2 H, CH2CO), 3.52-3.43 (m, 2 H), 3.12-3.05 (m, 4 H), 2.87-2.82 (m, 2 H). 13C NMR (125 MHz, DMSO-d
6): δ = 167.9, 152.7, 139.4, 136.1, 128.8, 128.7, 128.6, 128.5, 125.9, 125.7, 113.4, 113.2, 76.7, 71.3, 68.4, 38.6. HR-ESI (MeOH): m/z [M + Na]+ calcd for C21H24N2O6Na: 423.1532; found: 423.1542. Anal. Calcd for C21H24N2O6: C, 63.00; H, 6.00; N, 7.00. Found: C, 63.10; H, 6.01; N, 7.06.
14
Gryko DT.
Piątek P.
Jurczak J.
Tetrahedron
1997,
53:
7957
15
19-Benzyloxy-18-bromo-2,8,14-trioxa-5,11-diaza-bicyclo[13.3.1]nonadeca-1 (18),15 (19),16-triene-4,12-dione (
11). Purified by column chromatography (silica gel, EtOAc) to give 11 (1720 mg, 72%) as a white solid; mp 172.6-173.6 °C. 1H NMR (500 MHz, CDCl3): δ = 8.59-8.53 (br d, 1 H, NHCO), 7.99-7.93 (br d, 1 H, NHCO), 7.58-7.54 (m, 2 H), 7.46-7.41 (m, 3 H), 7.37 (d, J = 9 Hz, 1 H), 6.81 (d, J = 9 Hz, 1 H), 5.06 (dAB, J = 9.5 Hz, CH2Ph, 1 H), 4.99 (dAB, J = 9.5, CH2Ph, 1 H), 4.89 (dA1B1, J = 16.5, CH2CO, 1 H), 4.82 (dA2B2, J = 16.1 Hz, CH2CO, 1 H), 4.63 (dA1B1, J = 16.5 Hz, CH2CO, 1 H), 4.52 (dA2B2, J = 16.1 Hz, CH2CO), 3.80-3.71 (m, 2 H), 3.19-3.10 (m, 3 H), 3.04-2.99 (m, 1 H), 2.96-2.88 (m, 1 H), 2.64-2.57 (m, 1 H). 13C NMR (125 MHz, CDCl3): δ = 168.5, 168.1, 153.0, 151.3, 142.5, 134.9, 130.2, 129.8, 129.3, 128.8, 115.5, 109.1, 78.5, 73.8, 72.5, 69.3, 69.1, 38.9, 38.8. HR-ESI (MeOH): m/z [M + Na]+ calcd for C21H23N2O6
79BrNa: 501.0632; found: 501.0646. Anal. Calcd for C21H23N2O6Br: C, 52.62; H, 4.84; N, 5.84; Br, 16.67. Found: C, 52.49; H, 4.93; N, 5.63; Br, 16.52.
16
Piątek P.
Kalisiak J.
Jurczak J.
Tetrahedron Lett.
2004,
45:
3309
17
11-Bromo-26-(1-naphthylmethoxy)-2,8,15,21-tetraoxa-5,18-diaza-tricyclo[20.3.1.0*9,14*]hexacosa-1 (25),9 (14),10,12,22 (26),23-hexaene-4,19-dione (
12). Purified by column chromatography (silica gel, EtOAc) to give 12 (465 mg, 15%) as white solid; mp 166.5-167.8 °C. 1H NMR (500 MHz, CDCl3): δ = 8.30-8.26 (m, 1 H), 7.98-7.93 (m, 2 H, NHCO), 7.85-7.80 (m, 1 H), 7.74-7.67 (m, 2 H), 7.52-7.47 (m, 2 H), 7.35-7.30 (m, 1 H), 7.13 (t, 1 H, J = 8.4), 6.89 (dd, 1 H, J
1 = 8.6 Hz, J
2 = 2.2 Hz), 6.79-6.74 (m, 2 H), 6.55 (d, 1 H, J = 2.2 Hz), 6.36 (d, 1 H, J = 8.6 Hz), 5.47 (s, 2 H, CH2Naph), 4.79 (ddAB, J
1 = 8.2 Hz, J
2 = 15.6 Hz, 2 H, CH2CO), 4.58 (dAB, J = 15.6 Hz, 2 H, CH2CO), 3.90-3.80 (m, 2 H), 3.71-3.65 (m, 1 H), 3.62-3.52 (m, 3 H), 3.38-3.30 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ = 168.7, 168.6, 153.4, 153.3, 148.3, 146.8, 139.3, 133.5, 132.0, 131.5, 129.5, 128.9, 127.1, 126.4, 125.8, 125.7, 125.1, 123.4, 123.2, 115.4, 112.9, 112.7, 111.2, 111.0, 74.2, 70.9, 70.7, 67.3, 67.2, 38.6, 38.5. HR-ESI (MeOH): m/z [M + Na]+ calcd for C31H29N2O7
79BrNa: 643.1050, found: 643.1039. Anal. Calcd for C31H29N2O7Br: C, 59.91; H, 4.70; N, 4.51; Br, 12.86. Found: C, 60.01; H, 4.84; N, 4.38; Br, 12.74.
18 HPLC analyses for 11 and 12. Column: Chiralcel OD-H®, length 250 mm; i.d. 4.6 mm. For 11: i-PrOH-hexane, 3:1; flow rate 0.7 mL/min.; λ = 254 nm. For 12: i-PrOH-hexane, 1:1; flow rate 1.1 mL/min.; λ = 254 nm. Enantiomeric purities obtained: (+)11: 93% ee, [α]D
26 = +61.8 (c = 0.56, CHCl3); (-)11: 88% ee, [α]D
26 -59.3 (c = 0.55, CHCl3); (+)12: 99% ee, [α]D
26 = +18.9 (c = 0.37, CHCl3); (-)12: 94% ee, [α]D
26 -17.9 (c = 0.37, CHCl3).
19 CD experiments were measured in MeCN in a 0.1 cm cell at 24 °C.